Phase 2 trial results (48 weeks, adults with obesity): 1 mg dose: 7.2% body weight loss 4 mg dose: 12.9% body weight loss 8 mg dose: 17.3% body weight loss 12 mg dose: 24.2% body weight loss Placebo: 1.6% body weight loss Phase 3 TRIUMPH-4 results: 9 mg dose: 20.0% body weight loss (22.9 kg / 50.5 lbs) 12 mg dose: 23.7% body weight loss (27.2 kg / 60.0 lbs) Placebo: 4.6% body weight loss In a separate phase 3 analysis, retatrutide at the highest dose achieved up to 28.7% weight loss
Early in regenerative medicine, they seemed promising and were used in many ways: intravenous, intra-articular, intravaginal, and intralesional
Generally, people experience a sunburn-like sensation for a few hours to a few days following their treatment
Portal vein thrombosis: state-of-the-art review
There are many studies that have examined the link between antioxidants and inflammatory and oxidative pathways
Furthermore, the pathological forms of truncated -synuclein were also identified within a healthy human appendix (Killinger et al., 2018)
